Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability
Authors Zha YY, Yang B, Tang ML, Guo QC, Chen JT, Wen LP, Wang M
Received 16 February 2012
Accepted for publication 17 April 2012
Published 29 June 2012 Volume 2012:7 Pages 3099—3109
DOI https://doi.org/10.2147/IJN.S30934
Review by Single-blind
Peer reviewer comments 2
Ying-ying Zha,1 Bo Yang,1 Ming-liang Tang,2 Qiu-chen Guo,1 Ju-tao Chen,1 Long-ping Wen,3 Ming Wang1
1CAS Key Laboratory of Brain Function and Disease, School of Life Sciences, University of Science and Technology of China, Hefei, 2Suzhou Institute of NanoTech and NanoBionics, Chinese Academy of Sciences, Suzhou, 3Laboratory of Nano-biology, School of Life Sciences, University of Science and Technology of China, Hefei, People's Republic of China
Background: Recent studies have shown that the biological actions and toxicity of the water-soluble compound, polyhydroxyfullerene (fullerenol), are related to the concentrations present at a particular site of action. This study investigated the effects of different concentrations of fullerenol on cultured rat hippocampal neurons.
Methods and results: Fullerenol at low concentrations significantly enhanced hippocampal neuron viability as tested by MTT assay and Hoechst 33342/propidium iodide double stain detection. At high concentrations, fullerenol induced apoptosis confirmed by Comet assay and assessment of caspase proteins.
Conclusion: These findings suggest that fullerenol promotes cell death and protects against cell damage, depending on the concentration present. The concentration-dependent effects of fullerenol were mainly due to its influence on the reduction-oxidation pathway.
Keywords: fullerenol, nanomaterial, neurotoxicity, neuroprotection, hippocampal neuron
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other article by this author:
Suppression of synaptic plasticity by fullerenol in rat hippocampus in vitro
Wang XX, Zha YY, Yang B, Chen L, Wang M
International Journal of Nanomedicine 2016, 11:4947-4955
Published Date: 28 September 2016
Readers of this article also read:
Monitoring cancer stem cells: insights into clinical oncology
Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL
OncoTargets and Therapy 2016, 9:731-740
Published Date: 11 February 2016
A critical appraisal of the clinical utility of proton therapy in oncology
Wang D
Medical Devices: Evidence and Research 2015, 8:439-446
Published Date: 28 October 2015
Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M
Drug Design, Development and Therapy 2015, 9:5215-5223
Published Date: 11 September 2015
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
Kundranda MN, Niu J
Drug Design, Development and Therapy 2015, 9:3767-3777
Published Date: 24 July 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M
OncoTargets and Therapy 2015, 8:1149-1156
Published Date: 22 May 2015
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
Brueseke TJ, Tewari KS
Clinical Pharmacology: Advances and Applications 2013, 5:13-19
Published Date: 23 May 2013
Palliative nursing care for children and adolescents with cancer
Foster TL, Bell CJ, McDonald CF, Harris JS, Gilmer MJ
Nursing: Research and Reviews 2012, 2:17-25
Published Date: 15 June 2012
Multidisciplinary care in pediatric oncology
Cantrell MA, Ruble K
Journal of Multidisciplinary Healthcare 2011, 4:171-181
Published Date: 30 May 2011
Pegylated liposomal doxorubicin in the management of ovarian cancer
Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al
Therapeutics and Clinical Risk Management 2010, 6:463-483
Published Date: 29 September 2010
Use of electronic medical records in oncology outcomes research
Gena Kanas, Libby Morimoto, Fionna Mowat, et al
ClinicoEconomics and Outcomes Research 2010, 2:1-14
Published Date: 24 February 2010
